Validation of IMACS tools in Inclusion Body Myositis
Principal Investigator:
Dieter Pongratz, Sabine Krause, et al., Germany
Study Design:
Natural History study
Types & Number of IIM Studied:
Consecutive Inclusion Body Myositis (N = 50)
Entry Criteria:
Griggs et al. 1995 Ann Neurology Inclusion Body Myositis criteria
IMACS Core Set Measures Included:
Physician and Patient Global Activity and Damage Assessments, Manual
Muscle Testing, Health Assessment Questionnaire, muscle enzymes, Myositis
Disease Activity Assessment Tool; Myositis Damage Index
Other Measures Included:
Magnetic resonance imaging, Quantitative Muscle Testing, NSS
Primary Outcome:
NA
Study Duration:
Evaluation every 6 months for 24 months
Comments:
Will start early 2005
Contact:
Dr. Sabine Krause, email: sabine.krause@fbs.med.uni-muenchen.de; Dr.
Dieter Pongratz, email: dieter.pongratz@fbs.med.uni-muenchen.de
|